Artículos por temáticas

Editorial to the Special Issue "Lipidomics and Neurodegenerative Diseases"

Calvano CD, Losito I, Cataldi T.

Int J Mol Sci. 2021 Jan 28;22(3):1270. doi: 10.3390/ijms22031270.

Sexual Disorders and Quality of Life in Parkinson's Disease

Santa Rosa Malcher CM, Roberto da Silva Gonçalves Oliveira K, Fernandes Caldato MC, Lopes Dos Santos Lobato B, da Silva Pedroso J, de Tubino Scanavino M.

Sex Med. 2021 Jan 8;9(1):100280. doi: 10.1016/j.esxm.2020.10.008. Online ahead of print.

[Development of early diagnosis of Parkinson's disease and comprehensive economic analysis of the effect of its implementation]

Gusev EI, Blokhin VE, Vartanov SA, Martynov MY, Katunina EA, Alesenko AV, Denisova IA, Pavlova EN, Polterovich VM, Kucheryanu VG, Shupik MA, Nodel MR, Kalinkin AL, Sokolov SA, Chubarova TV, Shakleina

Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(1):9-20. doi: 10.17116/jnevro20211210119.

Social listening - revealing Parkinson's disease over day and night

Zhang H, Meng F, Li X, Ning Y, Cai M.

BMC Neurol. 2021 Jan 4;21(1):2. doi: 10.1186/s12883-020-02024-4.

How Time Rules: Diurnal Motor Patterns in de novo Parkinson's Disease

van Wamelen DJ, Urso D, Chaudhuri KR.

J Parkinsons Dis. 2021 Jan 23. doi: 10.3233/JPD-202352. Online ahead of print.

Correlation between depression and quality of life in patients with Parkinson's disease

Su W, Liu H, Jiang Y, Li S, Jin Y, Yan C, Chen H.

Clin Neurol Neurosurg. 2021 Mar;202:106523. doi: 10.1016/j.clineuro.2021.106523. Epub 2021 Jan 29.

Skin conditions in early Parkinson's disease

Dinesh D, Lee JS, Gao X, Palacios N.

Parkinsonism Relat Disord. 2021 Mar;84:40-46. doi: 10.1016/j.parkreldis.2021.01.018. Epub 2021 Jan 29.

Serum uric acid level as a putative biomarker in Parkinson's disease patients carrying GBA1 mutations: 2-Year data from the PPMI study

Koros C, Simitsi AM, Papagiannakis N, Bougea A, Prentakis A, Papadimitriou D, Pachi I, Antonelou R, Angelopoulou E, Beratis I, Bozi M, Papageorgiou SG, Trapali XG, Stamelou M, Stefanis L.

Parkinsonism Relat Disord. 2021 Mar;84:1-4. doi: 10.1016/j.parkreldis.2020.12.020. Epub 2021 Jan 20.

Pelvic Floor Health in Women with Parkinson's Disease

Gupta A, LaFaver K, Duque KR, Lingaiah A, Meriwether KV, Gaskins J, Gomes J, Espay AJ, Mahajan A.

J Parkinsons Dis. 2021 Feb 11. doi: 10.3233/JPD-202491. Online ahead of print.

Clinical Phenotypes of Parkinson's Disease Associate with Distinct Gut Microbiota and Metabolome Enterotypes

Vascellari S, Melis M, Palmas V, Pisanu S, Serra A, Perra D, Santoru ML, Oppo V, Cusano R, Uva P, Atzori L, Morelli M, Cossu G, Manzin A.

Biomolecules. 2021 Jan 22;11(2):144. doi: 10.3390/biom11020144.

A compound heterozygous PINK1-associated juvenile Parkinson's disease with pregnancy in Chinese

Li JY, Li NN, Wang L, Peng JX, Duan LR, Chen CL, Peng R.

J Neurol. 2021 Jun;268(6):2223-2227. doi: 10.1007/s00415-021-10405-z. Epub 2021 Jan 25.

Wearables in the home-based assessment of abnormal movements in Parkinson's disease: a systematic review of the literature

Ancona S, Faraci FD, Khatab E, Fiorillo L, Gnarra O, Nef T, Bassetti CLA, Bargiotas P.

J Neurol. 2021 Jan 6. doi: 10.1007/s00415-020-10350-3. Online ahead of print.

Insight into an unsupervised two-step sparse transfer learning algorithm for speech diagnosis of Parkinson's disease

Li Y, Zhang X, Wang P, Zhang X, Liu Y.

Neural Comput Appl. 2021 Feb 9:1-18. doi: 10.1007/s00521-021-05741-0. Online ahead of print.

Influence of dopamine, noradrenaline, and serotonin transporters on the pharmacogenetics of Atremorine in Parkinson's disease

Cacabelos R, Carrera I, Martínez O, Naidoo V, Cacabelos N, Aliev G, Carril JC.

Drug Dev Res. 2021 Aug;82(5):695-706. doi: 10.1002/ddr.21784. Epub 2021 Jan 17.

Harnessing the immune system for the treatment of Parkinson's disease

Vedam-Mai V.

Brain Res. 2021 May 1;1758:147308. doi: 10.1016/j.brainres.2021.147308. Epub 2021 Jan 29.